KLI

B-type natriuretic peptide as a surrogate marker for survival in patients undergoing cardiac surgery

Metadata Downloads
Abstract
Background: B-type natriuretic peptide (BNP) is a biomarker predicting morbidity and mortality in patients with congestive heart failure. However, the usefulness of preor postoperative BNP levels in patients undergoing cardiac surgery remains uncertain. We sought to determine the association of pre or postoperative BNP levels on mortality in patients undergoing cardiac surgery under cardiopulmonary bypass (CPB).

Methods: This study retrospectively evaluated 1,642 patients undergoing cardiac surgery under CPB over 2 years. The primary outcomes were 30-day and overall mortality after cardiac surgery.

Results: The 30-day mortality rate was 3.0% (n=49), and the overall mortality occurred in 118 patients during the mean follow-up period of 24.9 +/- 8.9 months. In multivariable analyses, preoperative BNP level was not significantly associated with 30-day [odds ratio (OR), 1.03; 95% confidence interval (CI), 0.99- 1.06; P=0.06] or overall [hazard ratio (HR), 1.01; 95% CI, 0.98-1.03; P=0.50] mortalities. However, the postoperative BNP level was significantly associated with 30-day (OR, 1.05; 95% CI, 1.02-1.09; P=0.001) and overall (HR, 1.03; 95% CI, 1.01-1.04; P=0.01) mortalities. As a sensitivity analysis, postoperative BNP levels were divided into quartiles. The top quartile (>_484 pg/mL) was identified as a strong predictor of overall mortality (HR, 2.18; 95% CI, 1.14-4.19; P=0.02).

Conclusions: Preoperative BNP level was not associated with mortality after cardiac surgery. However, postoperative BNP level was associated with mortality after cardiac surgery, especially in patients with high levels (>_484 pg/mL). Further studies in larger cohorts are necessary to validate these results.
Author(s)
임주영정성호주석중정철현이재원김준범
Issued Date
2021
Type
Article
Keyword
Natriuretic peptidebraincardiac surgical procedurescardiopulmonary bypass (CPB)heart failure
DOI
10.21037/jtd-20-2375
URI
https://oak.ulsan.ac.kr/handle/2021.oak/8766
https://ulsan-primo.hosted.exlibrisgroup.com/primo-explore/fulldisplay?docid=TN_cdi_proquest_miscellaneous_2501476989&context=PC&vid=ULSAN&lang=ko_KR&search_scope=default_scope&adaptor=primo_central_multiple_fe&tab=default_tab&query=any,contains,B-type%20natriuretic%20peptide%20as%20a%20surrogate%20marker%20for%20survival%20in%20patients%20undergoing%20cardiac%20surgery&offset=0&pcAvailability=true
Publisher
JOURNAL OF THORACIC DISEASE
Location
홍콩
Language
영어
ISSN
2072-1439
Citation Volume
13
Citation Number
2
Citation Start Page
955
Citation End Page
967
Appears in Collections:
Medicine > Medicine
Authorize & License
  • Authorize공개
Files in This Item:
  • There are no files associated with this item.

Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.